Karolinska Development :: View by company A-Z

Aprea Therapeutics AB Aprea is developing pharmaceuticals that reactivates the tumor suppressor protein p53, which is impaired in many instances of cancer. www.aprea.com	Dilafor AB Dilafor is dedicated to the development of pharmaceutical products aimed at minimizing the risk for protracted labor and associated complications. www.dilafor.com	Forendo Pharma Oy Forendo Pharma develops novel pharmaceutical treatments for endometriosis and for male patients with low testosterone levels. www.forendo.com
Modus Therapeutics AB Modus is developing innovative treatments for patients with sickle-cell disease based on a heparin analogue, sevuparin. Sickle-cell disease is a painful, inherited blood disorder affecting millions of people around the globe. www.modustx.com	OssDsign AB OssDsign is developing pioneering implants for bone healing with an initial focus on skull surgery. www.ossdsign.com	Promimic AB Promimic develops and markets a nano-based surface applied to dental and bone implants for improved integration to bone and soft tissue www.promimic.com
Umecrine Cognition AB Umecrine Cognition is developing a therapy that represents a new target class for several major CNS-related disorders. www.umecrinecognition.com	Pharmanest AB Pharmanest is specialized in the development of new topical analgesic formulations to be used on the mucosa. www.pharmanest.se	Asarina Pharma AB Asarina Pharna is developing innovative and targeted products to treat women with disorders associated with the menstrual cycle. www.asarinapharma.com